ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
127.308,80
-0,95%
S&P 500
6.144,15
0,24%
US Dollar vs BRL
5,7214
-0,01%
Bitcoin
97.162,43
0,55%
Brent Oil
75,525
-0,39%
As Melhores Corretoras Online
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Addex Therapeutics Ltd (ADXN)

  7. Addex Therapeutics Ltd (ADXN) Notícias

ADXN

Addex Therapeutics (ADXN)

Addex Therapeutics Ltd
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:ADXN
DataHoraFonteTítuloCódigoCompanhia
08/01/202503:00GlobeNewswire Inc.Addex to Present at the 2025 Swiss Equities Baader ConferenceNASDAQ:ADXNAddex Therapeutics Ltd
22/11/202408:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ADXNAddex Therapeutics Ltd
22/11/202403:00GlobeNewswire Inc.Addex Reports Third Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:ADXNAddex Therapeutics Ltd
11/11/202403:00GlobeNewswire Inc.Addex Provisional 2024 Third Quarter Results Showed Net Loss Compared to Second Quarter 2024NASDAQ:ADXNAddex Therapeutics Ltd
30/09/202402:00GlobeNewswire Inc.Addex Therapeutics Reports 2024 Half Year and Second Quarter Financial Results and Provides Corporate UpdateNASDAQ:ADXNAddex Therapeutics Ltd
19/09/202402:00GlobeNewswire Inc.Addex Provisional 2024 Half-Year and Second Quarter Result increased from a Net loss to a Net ProfitNASDAQ:ADXNAddex Therapeutics Ltd
04/09/202402:00GlobeNewswire Inc.Addex to Participate in the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:ADXNAddex Therapeutics Ltd
27/08/202402:00GlobeNewswire Inc.Addex and Indivior Select Clinical Candidates from GABAB Positive Allosteric Modulator Research CollaborationNASDAQ:ADXNAddex Therapeutics Ltd
14/08/202421:12Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:ADXNAddex Therapeutics Ltd
22/07/202402:00GlobeNewswire Inc.Addex’s Partner Discontinues ADX71149 development in EpilepsyNASDAQ:ADXNAddex Therapeutics Ltd
15/07/202402:00GlobeNewswire Inc.Addex Presents Positive Results from GABAB PAM Cough Program at the Thirteenth London International Cough Symposium (13th LICS)NASDAQ:ADXNAddex Therapeutics Ltd
12/07/202402:00GlobeNewswire Inc.Addex To Present at the Thirteenth London International Cough Symposium (13th LICS)NASDAQ:ADXNAddex Therapeutics Ltd
01/07/202402:00GlobeNewswire Inc.Addex Shareholders Approve All Resolutions at Annual General MeetingNASDAQ:ADXNAddex Therapeutics Ltd
06/06/202408:29IH Market NewsUS Index Futures Mixed; Oil Prices RiseNASDAQ:ADXNAddex Therapeutics Ltd
06/06/202402:00GlobeNewswire Inc.Addex Therapeutics Reports Q1 2024 Financial Results and Provides Corporate UpdateNASDAQ:ADXNAddex Therapeutics Ltd
05/06/202402:00GlobeNewswire Inc.Addex Convenes Annual General Meeting 2024NASDAQ:ADXNAddex Therapeutics Ltd
31/05/202402:00GlobeNewswire Inc.Addex Therapeutics to Release Q1 2024 Financial Results and Host Conference Call on June 6, 2024NASDAQ:ADXNAddex Therapeutics Ltd
08/05/202402:00GlobeNewswire Inc.Addex to Present at Bio€quity Europe 2024NASDAQ:ADXNAddex Therapeutics Ltd
29/04/202402:00GlobeNewswire Inc.Addex Provides Update on ADX71149 Phase 2 Epilepsy StudyNASDAQ:ADXNAddex Therapeutics Ltd
19/04/202402:00GlobeNewswire Inc.Addex to Present at the Swiss Biotech Day 2024NASDAQ:ADXNAddex Therapeutics Ltd
18/04/202402:00GlobeNewswire Inc.Addex Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:ADXNAddex Therapeutics Ltd
11/04/202402:00GlobeNewswire Inc.Addex Therapeutics to Release Full-Year 2023 Financial Results and Host Conference Call on April 18, 2024NASDAQ:ADXNAddex Therapeutics Ltd
03/04/202402:00GlobeNewswire Inc.Addex and Perceptive Launch Neurosterix with $63 Million to Accelerate Development of Allosteric Modulator Therapeutics for Neurological DisordersNASDAQ:ADXNAddex Therapeutics Ltd
14/03/202403:00GlobeNewswire Inc.Addex to Present at the Bio-Europe Spring 2024 ConferenceNASDAQ:ADXNAddex Therapeutics Ltd
31/01/202403:00GlobeNewswire Inc.Addex Enters into At-The-Market ADS Offering Agreement with H.C. Wainwright & Co. LLC.NASDAQ:ADXNAddex Therapeutics Ltd
30/01/202419:00Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ADXNAddex Therapeutics Ltd
09/01/202403:00GlobeNewswire Inc.Addex to Present at the Swiss Equities Baader ConferenceNASDAQ:ADXNAddex Therapeutics Ltd
05/01/202403:30GlobeNewswire Inc.Addex to Present at Biotech Showcase™ 2024NASDAQ:ADXNAddex Therapeutics Ltd
21/12/202308:00Edgar (US Regulatory)Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]NASDAQ:ADXNAddex Therapeutics Ltd
20/12/202303:00GlobeNewswire Inc.Addex Shareholders Approve All Resolutions at Extraordinary General MeetingNASDAQ:ADXNAddex Therapeutics Ltd
 Apresentando as notícias mais relevantes sobre:NASDAQ:ADXN

Seu Histórico Recente

BOV
PDGR3
PDG REALT ON
BOV
IBOV
Índice Bovespa
BOV
PRIO3
PETRORIO ON
BOV
TELB4
TELEBRAS PN
BOV
COGN3
COGNA ON
BOV
BRAV3
Brava Energia ON
BOV
GFSA3
GAFISA ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2025 ADVFN PLC - Todos os direitos reservados

Vá sem anúncios

Assine uma experiência sem anúncios

Sem anúncios

Experimente agora

Manter os anúncios